Elicio Therapeutics, Inc. (ELTX)
NGS · Common · CUSIP 28657F103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ELTX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
28657F103 (prev. 03476J107 )
Market Cap
Micro Cap
IPO
2/5/2021 · $16.00/share
Previous Symbol
ANGN (changed 6/2/2023)
Previous Name
Angion Biomedica Corp.
Business: Elicio Therapeutics is a clinical-stage biotechnology company engineering investigational lymph node-targeted vaccines for an array of aggressive cancers and infectious diseases.

Company Contact

CEO
Robert Connelly
CFO
Preetam Shah
Headquarters
451 D Street, 5th Floor Boston, MA 02210
Phone
857-209-0050
Investor Relations
Heather DiVecchia · 857-209-0153 · IR@elicio.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »